TP53 and melanoma: In turn, diosgenin—a stereoisomer of yamogenin strongly inhibited the proliferation of laryngocarcinoma HEp-2 and melanoma M4Beu cells, blocked the cell cycle in S and G2/M phases, and activated p53 [31].